Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 79
Number of items: 79
  • Open Access
    van der Meer, A. N. (2023). Neglected treatable traits in adult asthma. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    van Kempen, Z. L. E., Stalman, E. W., Steenhuis, M., Kummer, L. Y. L., van Dam, K. P. J., Wilbrink, M. F., Ten Brinke, A., van Ham, S. M., Kuijpers, T., Rispens, T., Eftimov, F., Wieske, L., Killestein, J., & T2B! immunity against SARS-CoV-2 study group (2023). SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 94(4), 280-283. https://doi.org/10.1136/jnnp-2022-330100
  • Open Access
    Marsman, C. (2023). Regulation of human B cell differentiation. [Thesis, fully internal, Universiteit van Amsterdam].
  • Open Access
    van Dam, K. P. J., Hogenboom, L., Stalman, E. W., Kummer, L. Y. L., Steenhuis, M., Keijser, J. B. D., ten Brinke, A., van Ham, S. M., Kuijpers, T. W., Rispens, T., Wieske, L., Eftimov, F., Strijbis, E. M., Killestein, J., van Kempen, Z. L. E., & T2B! immunity against SARS-CoV-2 study group (2022). Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination. Frontiers in Neurology, 13, Article 1032830. https://doi.org/10.3389/fneur.2022.1032830
  • Open Access
    Wieske, L., Takkenberg, R. B., Tas, S. W., Bemelman, F. J., ten Brinke, A., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases. BMC Medicine, 20, Article 100. https://doi.org/10.1186/s12916-022-02310-7
  • Open Access
    Koers, J., Marsman, C., Steuten, J., Tol, S., Derksen, N. I. L., ten Brinke, A., van Ham, S., & Rispens, T. (2022). Oxygen level is a critical regulator of human B cell differentiation and IgG class switch recombination. Frontiers in Immunology, 13, Article 1082154. https://doi.org/10.3389/fimmu.2022.1082154
  • Open Access
    Marsman, C., Verstegen, N. J. M., Streutker, M., Jorritsma, T., Boon, L., Ten Brinke, A., & van Ham, S. M. (2022). Termination of CD40L co-stimulation promotes human B cell differentiation into antibody-secreting cells. European journal of immunology, 52(10), 1662-1675. https://doi.org/10.1002/eji.202249972
  • Open Access
    Verstegen, N. J. M., Hagen, R. R., van den Dijssel, J., Kuijper, L. H., Kreher, C., Ashhurst, T., Kummer, L. Y. L., Steenhuis, M., Duurland, M., de Jongh, R., de Jong, N., van der Schoot, C. E., Bos, A. V., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2022). Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. eLife, 11, Article e77969. https://doi.org/10.7554/eLife.77969
  • Open Access
    Palomares Cabeza, V., Kummer, L. Y. L., Wieske, L., Hagen, R. R., Duurland, M., Konijn, V. A. L., van Dam, K. P. J., Stalman, E. W., van de Sandt, C. E., Boekel, L., Verstegen, N. J. M., Steenhuis, M., Rispens, T., Tas, S. W., Wolbink, G., Killestein, J., Kuijpers, T. W., van Ham, S. M., Eftimov, F., ... Target-to-B! (T2B!) SARS-CoV-2 study group (2022). Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. Neurology® Neuroimmunology & Neuroinflammation, 9(4), Article e1178. https://doi.org/10.1212/NXI.0000000000001178
  • Open Access
    Marsman, C., Verhoeven, D., Koers, J., Rispens, T., ten Brinke, A., van Ham, S. M., Kuijpers, T. W., & T2B Consortium (2022). Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells. Frontiers in Immunology, 13, Article 815449. https://doi.org/10.3389/fimmu.2022.815449
Page 4 of 8